SSA published SSR
17-3p, “Evaluating Cases Involving Sickle Cell Disease (SCD)” on September 15, 2017. This
Social Security Ruling (SSR), which took effect upon publication, provides guidance
for assessing SCD under the hematological disorder listings and determining how this
impairment may affect the residual functional capacity finding for adults and the
functional equivalence finding for children.